Overexpressed miR-99b in blood and NK cells in patients with ME/CFS was previously reported [100], suggesting an mTOR signaling pathway and, subsequently, a reduction in NK cell cytotoxic and cytokine effector function [117,118]. The gene discussed is MTOR; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.